Patient-derived mesenchymal stem cells as delivery vehicles for oncolytic virotherapy: novel state-of-the-art technology

Oncolytic virotherapy is gaining interest in the clinic as a new weapon against cancer. In vivo administration of oncolytic viruses showed important limitations that decrease their effectiveness very significantly: the antiviral immune response causes the elimination of the therapeutic effect, and t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramírez, Manuel, García-Castro, Javier, Melen, Gustavo J, González-Murillo, África, Franco-Luzón, Lidia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918392/
https://www.ncbi.nlm.nih.gov/pubmed/27512678
http://dx.doi.org/10.2147/OV.S66010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918392/
https://www.ncbi.nlm.nih.gov/pubmed/27512678
http://dx.doi.org/10.2147/OV.S66010

Ejemplares similares